↓ Skip to main content

Nano to micro delivery systems: targeting angiogenesis in brain tumors

Overview of attention for article published in Vascular Cell, October 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)

Mentioned by

blogs
1 blog
twitter
1 X user
patent
1 patent

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
67 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Nano to micro delivery systems: targeting angiogenesis in brain tumors
Published in
Vascular Cell, October 2010
DOI 10.1186/2040-2384-2-20
Pubmed ID
Authors

Ariel Gilert, Marcelle Machluf

Abstract

Treating brain tumors using inhibitors of angiogenesis is extensively researched and tested in clinical trials. Although anti-angiogenic treatment holds a great potential for treating primary and secondary brain tumors, no clinical treatment is currently approved for brain tumor patients. One of the main hurdles in treating brain tumors is the blood brain barrier - a protective barrier of the brain, which prevents drugs from entering the brain parenchyma. As most therapeutics are excluded from the brain there is an urgent need to develop delivery platforms which will bypass such hurdles and enable the delivery of anti-angiogenic drugs into the tumor bed. Such delivery systems should be able to control release the drug or a combination of drugs at a therapeutic level for the desired time. In this mini-review we will discuss the latest improvements in nano and micro drug delivery platforms that were designed to deliver inhibitors of angiogenesis to the brain.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Nepal 1 1%
China 1 1%
Switzerland 1 1%
Unknown 63 94%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 17 25%
Student > Bachelor 9 13%
Student > Master 8 12%
Student > Doctoral Student 7 10%
Researcher 4 6%
Other 12 18%
Unknown 10 15%
Readers by discipline Count As %
Agricultural and Biological Sciences 14 21%
Medicine and Dentistry 11 16%
Pharmacology, Toxicology and Pharmaceutical Science 6 9%
Engineering 6 9%
Chemistry 4 6%
Other 14 21%
Unknown 12 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 October 2023.
All research outputs
#2,847,096
of 25,374,917 outputs
Outputs from Vascular Cell
#8
of 72 outputs
Outputs of similar age
#11,061
of 108,204 outputs
Outputs of similar age from Vascular Cell
#1
of 2 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 72 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 108,204 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them